XML 67 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value Measurements
9 Months Ended
Sep. 30, 2015
Fair Value Disclosures [Abstract]  
Fair Value Measurements
FAIR VALUE MEASUREMENTS
The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market. The principal market is the market with the greatest level of activity and volume for the asset or liability. Absent a principal market to measure fair value, the Company has used the most advantageous market, which is the market in which the Company would receive the highest selling price for the asset or pay the lowest price to settle the liability, after considering transaction costs. However, when using the most advantageous market, transaction costs are only considered to determine which market is the most advantageous and these costs are then excluded when applying a fair value measurement.
Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.
The three levels of the fair value hierarchy are as follows:
Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in non-active markets; and model derived valuations whose inputs are observable or whose significant valuation drivers are observable.
Level 3 – significant inputs to the valuation model are unobservable and/or reflect the Company’s market assumptions.
Recurring Fair Value Measurements
The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis:
 
 
 
Fair Value Measurement Using
 (amounts in millions)
September 30,
2015
 
Quoted prices in
active markets
(Level 1)
 
Significant
other observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Asset Category
 
 
 
 
 
 
 
Money market accounts
$
36.2

 
$
36.2

 
$

 
$

Available for sale equity securities
6.9

 
6.2

 
0.7

 

Derivatives
1.2

 

 
1.2

 

Total
$
44.3

 
$
42.4

 
$
1.9

 
$

Liability Category
 

 
 

 
 

 
 

Long term contingent consideration
$
70.2

 
$

 
$

 
$
70.2

Derivatives
66.7

 

 
18.6

 
48.1

Total
$
136.9

 
$

 
$
18.6

 
$
118.3

 
 
 
Fair Value Measurement Using
 (amounts in millions)
December 31, 2014
 
Quoted prices in
active markets
(Level 1)
 
Significant
other observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Asset Category
 
 
 
 
 
 
 
Money market accounts
$
15.4

 
$
15.4

 
$

 
$

Available for sale equity securities
2.3

 
1.5

 
0.8

 

Total
$
17.7

 
$
16.9

 
$
0.8

 
$

Liability Category
 

 
 

 
 

 
 

Long term contingent consideration
$
63.9

 
$

 
$

 
$
63.9

Derivatives
0.1

 

 
0.1

 

Total
$
64.0

 
$

 
$
0.1

 
$
63.9


Money market accounts are included in "Cash and cash equivalents" in the Condensed Consolidated Balance Sheets. Available for sale equity securities are included in "Other assets" in the Condensed Consolidated Balance Sheets.
The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial instruments, assets and liabilities:
Money market accounts - The Company invests in various money market funds which are managed by financial institutions. These money market funds are not publicly traded, but historically have been highly liquid. The fair value of the money market accounts is determined by the banks based upon the funds’ net asset values, or NAV. All of the money market accounts currently permit daily investments and redemptions at $1.00 NAV.
Available for sale equity securities - Equity securities classified as available for sale are measured using quoted market prices at the reporting date multiplied by the quantity held. Level 2 equity securities are measured using quoted prices for similar instruments in active markets.
Derivatives - The fair values of our derivative assets and liabilities include foreign currency and interest rate derivatives. The values were determined using pricing models based upon observable market inputs, and for the deal contingent forward purchase derivative, the value was determined using pricing models based on third party pricing valuations of broker/ dealer quotations not based upon observable market inputs.
Long term contingent consideration - The long term contingent consideration represents a potential liability of up to $100 million tied to achievement of EBITDA and common stock trading price performance metric over a seven-year period ending December 2020 in connection with the MacDermid Acquisition. The common stock performance metric has been satisfied. The fair value of the EBITDA performance metric is derived using the income approach with unobservable inputs, based on future forecasts and present value assumptions which include a discount rate of approximately 1.5% and expected future value of payments of $60.0 million calculated using a probability weighted EBITDA assessment with higher probability associated with the Company achieving the maximum EBITDA targets. For the three and nine month ended September 30, 2015, the fair value of the long term contingent consideration increased by $2.7 million and $6.3 million, respectively. For the three and nine month ended September 30, 2014, the fair value of the long term contingent consideration increased by $2.3 million and $26.1 million, respectively. Changes in the fair value of the long term contingent consideration is recorded in "Selling, technical, general and administrative expenses" in the Condensed Consolidated Statement of Operations. An increase or decrease in the discount rate of 1% changes the fair value measure of the share price metric by $2.0 million.
As of September 30, 2015 and 2014, there were no significant transfers between the fair value hierarchy levels.
Nonrecurring Fair Value Measurements
The following table presents the carrying value and estimated fair value of the Company’s long term debt and capital lease obligations:
 (amounts in millions)
September 30, 2015
 
December 31, 2014
Long term debt - including current portion
Carrying
Value
 
Fair Value
 
Carrying
Value
 
Fair Value
USD Notes, due 2022, interest at 6.50%
$
1,080.3

 
$
935.0

 
$

 
$

EUR Notes, due 2023, interest at 6.00%
384.9

 
334.5

 

 

First Lien Credit Facility
737.4

 
712.0

 
743.0

 
721.4

USD Incremental Loan
291.3

 
286.6

 
292.7

 
286.0

New Tranche B Term Loan
121.9

 
124.2

 
121.7

 
125.2

New Tranche B-2 Term Loan
481.7

 
478.9

 

 

Euro Tranche Term Loan
225.9

 
218.9

 
246.2

 
245.8

New Euro Tranche Term Loan
89.8

 
88.9

 

 

Capital lease obligations
4.3

 
4.2

 
2.0

 
2.6

Total
$
3,417.5

 
$
3,183.2

 
$
1,405.6

 
$
1,381.0

 
The following methods and assumptions were used to estimate the fair value of the Company’s long term debt:
Long-term Debt Instruments - These financial instruments are measured using quoted market prices at the reporting date multiplied by the gross carrying amount of the related debt. Such instruments are valued using Level 2 inputs.